General
All chemicals and solvents purchased from Sigma-Aldrich were used without further purification. Spectra of 1 H NMR and 13 C NMR were recorded using a Bruker DPX-400 in CDCl 3 with TMS as internal reference. Splitting in the spectra are shown as s (singlet), d (doublet), t (triplet), q (quartet), m (multiplet), dd (doublet of doublet), and br (broad).
Absorption spectrometry was performed using a Varian spectrophotometer. Steady state fluorescence measurements were conducted using a Varian Eclipse spectrofluorometer. Column chromatography of all products was performed using Merck Silica Gel 60 (particle size: 0.040-0.063 mm, 230-400 mesh ASTM). Reactions were monitored by thin layer chromatography using fluorescent coated aluminum sheets. Solvents used for spectroscopy experiments were spectrophotometric grade.
Flourescence life time measurements were determined on a HORIBA Jobin Yvon fluorolog, FL-1057.
HORIBA Scientific NanoLEDs at 650 and 667 nm (pulse width < 250 ps) was used. The instrument response function was measured with an aqueous Ludox solution. The decays were analyzed with a multi-exponential fitting function by iterative reconvolution and chi-square minimization. Mass spectra were recorded on Agilent Technologies 6530 Accurate-Mass Q-TOF LC/MS.
FRET efficiency was determined using time-resolved approach with the formula below:
where  D and  DA refer to excited state decay time (lifetime) of protonated donor (protonated compound 2) alone and donor as a part of theragnostic agent (protonated compound 3) respectively. Both measurements were done in acidic conditions and absorbance values are all below 0.1 to avoid inner filter effect. 
Singlet Oxygen Generation Experiment
Singlet oxygen generation capability of theragnostic compound was detected using the bleaching of singlet oxygen trap molecule 1,3-diphenylisobenzofuran (DPBF). For light source 625 nm emitting LED source was used. A solution containing DPBF (50 M), theragnostic compound (20 nM) and trifluoroacetic acid (20l/3ml) was prepared in chloroform. Two negative control solutions were prepared with DPBF alone (50 M) (with TFA and without TFA) and DPBF (50 M) with compound 3 (20 nM ) (without TFA). As positive control, a solution with DPBF (50 M) and photosensitizer (PS, 1) (20 nM ) was prepared. Solutions were aerated for 5 minutes. Then, absorbance spectrum of each sample was taken in 5 minutes intervals while the solutions were kept in dark. Then 625 nm light was exposed from 10 cm cell distance for 45 minutes and absorbance was taken in 5 minutes intervals for each solution. No decrease in absorbance was observed in negative controls and in dark while there is a substantial decrease in both positive controls and in solution containing compound 3.
Relative singlet oxygen generation efficiencies were calculated by using the decrease in absorbance of DPBF at 411 nm. Absorbance of DPBF at 411 nm during 625 nm light irradiation was plotted with respect to time and slope was calculated for compound 1 and protonated compound 3. For each compounds singlet oxygen generation efficiencies were taken as 1 and others species of each compound were normalized accordingly (by dividing each slope to the calculated slope of PS or protonated compound 3). The decrease in the efficiency of PS in the presence of acid is probably due to decrease in spectral match of lamp after the bathochromic shift in PS. For TFA containing samples, the background irradiation-independent decrease in trap absorbance due to decomposition of DPBF was eliminated from the data by subtracting the slope of this control graph.
4 Figure S1 . Absorbance (a) and excitation spectra (b) of 2 M of molecular demultiplexer (compound 3) in the absence and presence of acid in chloroform. Overlapping peaks result in the observed broad absorption peak.
Emission was collected at 715 nm and at 700 nm for compound 3 and acid-added compound 3 respectively.
Emission spectra of module compounds 1 and 2 (2 M) in acidic and neutral media in chloroform (c). 6 Table S1 . Results of singlet oxygen generation in positive and negative control experiments. 
Synthesis of Compound B
3,5-di(2-ethylhexyl)benzylalcohol, compound A (4.2 g, 11.6 mmol) and pyridinium chlorochromate (5 g, 20 mmol) were dissolved in 50 ml dichloromethane. The reaction mixture was stirred at room temperature for 30 minutes. Then, the crude product was filtered from celite, filtrate was collected, vacuum evaporated. The product was purified by silica gel column chromatography using CHCl 3 as mobile phase. Fraction containing compound B was collected then the solvent was removed under reduced pressure (3.91 g, 10.8 mmol, 93% 5, 160.9, 138.4, 107.8, 107.3, 70.6, 39.3, 30.5, 29.0, 23.8, 23 .0, 14.0, 11.0.
Electronic Supplementary Material (ESI) for Chemical Science
This journal is © The Royal Society of Chemistry 2012
Synthesis of Compound 1a
CH 2 Cl 2 (300 ml) was purged with Ar for 30 min. 3,5-di(2-ethylhexyl)benzaldehyde, compound B (1.76 g, 4.85 mmol) and 2,4-dimethyl pyrrole (1 ml, 9.71 mmol) were added.
The color of the solution turned into red after the addition of 3 drops of trifluoroacetic acid.
The reaction mixture was stirred at room temperature for 12h. Then, tetrachloro-1,4-benzoquinone (1.192 g, 9.7 mmol) was added and the reaction mixture was stirred at room temperature for 45 min. Then triethyl amine (6 ml) and boron trifluoride diethyl etherate (6 ml) were added sequentially. After stirring at room temperature for 30 min, it was extracted with water. Organic layer was dried with Na 2 SO 4 and evaporated under reduced pressure.
The product was purified by silica gel column chromatography using CHCl 3 /Hexane 
Synthesis of Compound 2a
CH 2 Cl 2 (300 ml) was purged with Ar for 30 min. 3, 5-di(2-ethylhexyl)benzaldehyde, compound B (1.3 g, 3.57 mmol) and 2,4-dimethyl-5-ethyl pyrrole (0.96 ml, 7.14 mmol) were added. The color of the solution turned into red after the addition of 3 drops of trifluoroacetic acid. The reaction mixture was stirred at room temperature for 12h. Then, tetrachloro-1,4-benzoquinone (878 mg, 3.57 mmol) was added and the reaction mixture was stirred at room temperature for 45 min. Then triethyl amine (7 ml) and boron trifluoride diethyl etherate (7 ml) were added sequentially. 
Synthesis of Compound C
4-hydroxybenzaldehyde (2.45 g, 20 mmol) and propargyl bromide (2.5 g, 30 mmol)
were dissolved in 100 ml acetonitrile. K 2 CO 3 (5.5 g, mmol) and a few crystals of benzo-18-crown-6 were added. The reaction was refluxed until all 4-hydroxybenzaldehyde was consumed. The solvent was evaporated in vacuo, extracted with water and CHCl 3 . Organic layer was dried with Na 2 SO 4 and evaporated under reduced pressure. The product was purified by silica gel column chromatography using CHCl 3 /Hexane (50:50, v/v). Fraction containing compound C was collected then the solvent was removed under reduced pressure (2.85 g, 17.8 mmol, 89% 13 C NMR (CDCl 3 , 100 MHz, ppm) 190.8, 164. 1, 132.0, 129.8, 114.7, 68.1, 51.3, 28.9, 28.7, 26.4, 25.6 
Synthesis of Compound 1b
Compound 1a (300 mg, 0.516 mmol) and I 2 (328 mg, 1.29 mmol) were dissolved in ethanol (150 ml). Iodic acid, HIO 3 (181.6 mg, 1.32 mmol) was dissolved in a few drops of water and adde into previous solution. The reaction mixture was stirred at 60 o C for a few hours untill all reeactant was consumed. After the reaction was completed, saturated sodium thiosulfate solution was added (50 ml) and it was stirred at room temparature for additional 30 min. Following that, it was extracted with CHCl 3 and water. Organic layer was dried with Na 2 SO 4 and evaporated under reduced pressure. The product was purified by silica gel column chromatography using CHCl 3 /Hexane (50:50, v/v). Fraction containing compound 1b was collected, the solvent was removed under reduced pressure (280 mg, 0.34 mmol, 66%). ArCH 3 ), 1.2-1.5 (m, 16H; CH 2 ), 0.91 (m, 12H; CH 3 ) 13 C NMR (CDCl 3 , 100 MHz, ppm) 55161. 7, 156.7, 145.4, 141.5, 136.0, 131.0, 106.0, 102.6, 85.5, 71.1, 39.3, 30.5, 29.1, 23.9, 23.0, 16.9, 16 .0, 14.1, 11.1. 
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Synthesis of Compound 1c
Compound 1b (200 mg, 0.24 mmol) and compound C (31 mg, 0.19 mmol) were dissolved in benzene (40 ml). Piperidine (0.3 ml) and acetic acid (0.3 ml) were added. The reaction mixture was refluxed using Dean Stark apparatus until all aldehyde was consumed.
After the reaction was completed, it was extracted with CHCl 3 and water. Organic layer was collected and dried with Na 2 SO 4 , evaporated under reduced pressure. The product was purified by silica gel column chromatography using CHCl 3 / Hexane (50:50, v/v 7, 158.5, 156.9, 150.4, 146.1, 145.1, 140.2, 138.6, 136.3, 132.0, 131.7, 130.4, 129.1, 117.1, 115.3, 106.3, 102.6, 106.3, 102.6, 86.1, 82.1, 78.3, 75.8, 71.1, 55.9, 39.3, 30.5, 29.1, 23.8, 23.0, 17.3, 16.9, 16.2, 14.1, 11 
Synthesis of 1 (PS)
Compound 1c (75 mg, 0.075 mmol) and 4-pyridinecarboxaldehyde (17 mg, 0.15 mmol) were dissolved in benzene (40 ml). Piperidine (0.3 ml) and acetic acid (0.3 ml) were added. The reaction mixture was refluxed using Dean Stark apparatus until all aldehyde was consumed. After the reaction was completed, it was extracted with CHCl 3 and water. Organic layer was collected and dried with Na 2 SO 4 , evaporated under reduced pressure. The product was purified by silica gel column chromatography using CHCl 3 /MetOH (95:5, v/v 8, 158.9, 152.7, 150.3, 148.1, 147.5, 144.9, 144.3, 140.7, 139.9, 136.3, 134.8, 130.1, 129.5, 123.3, 121.5, 116.9, 115.4, 106.4, 102.7, 78.2, 75.9, 71.1, 55.9, 39.3, 30.5, 29.7, 29.1, 23.9, 23.0, 17.7, 17.1, 14 
Synthesis of Compound 2b
Compound 2a (200 mg, 0.314 mmol) and 4-dimethylaminobenzaldehyde (37.5 mg, 0.25 mmol) were dissolved in benzene (40 ml). Piperidine (0.3 ml) and acetic acid (0.3 ml)
were added. The reaction mixture was refluxed using Dean Stark apparatus until all aldehyde was consumed. After the reaction was completed, it was extracted with CHCl 3 and water.
Organic layer was collected and dried with Na 2 SO 4 , evaporated under reduced pressure. The product was purified by silica gel column chromatography using CHCl 3 /Hexane (75:25, v/v).
Fraction containing compound 2b was collected then the solvent was removed under reduced pressure (0.039 mmol, 30 mg, 16% 13 C NMR (CDCl 3 , 100 MHz, ppm) 161. 5, 150.9, 150.8, 139.0, 138.5, 137.5, 136.2, 133.0, 132.7, 131.8, 131.1, 131.0, 128.7, 115.8, 115.7, 112.2, 107.0, 102.2, 71.0, 40.4, 39.3, 30.5, 29.1, 23.8, 23.0, 18.5, 17.2, 14.7, 14.1, 14.0, 12.6, 11.5, 11.3, 11 
Synthesis of 2 (FL)
Compound 2b (30 mg, 0.039 mmol) and compound E (11.6 mg, 0.047 mmol) were dissolved in benzene (40 ml). Piperidine (0.2 ml) and acetic acid (0.2 ml) were added. The reaction mixture was refluxed using Dean Stark apparatus until all aldehyde was consumed.
After the reaction was completed, it was extracted with CHCl 3 and water. Organic layer was collected and dried with Na 2 SO 4 , evaporated under reduced pressure. The product was purified by silica gel column chromatography using CHCl 3 /Hexane (75:25, v/v). Fraction containing compound 2 (FL) was collected then the solvent was removed under reduced pressure (0.022 mmol, 21.5 mg, 56 % ).
